5 December 2024
Latham & Watkins Advises Revolution Medicines in Upsized US$750 Million Public Offering of Common Stock and Pre-Funded Warrants
Advising firms
Deal team
17 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mark Roeder Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| John Williams Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Zuza Gruca | Latham & Watkins LLP | Associate | corporate | Not stated |
| Lexi Zintel | Latham & Watkins LLP | Associate | corporate | Not stated |
| John Manthei | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Heather Deixler | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Betty Pang | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Nathan Beaton | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Leia Gu | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Evan Miller | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Derek Gumm | Latham & Watkins LLP | Associate | tax | Not stated |
| Rasha Suleiman | Latham & Watkins LLP | Associate | tax | Not stated |
| Christopher Hazuka | Latham & Watkins LLP | Partner | intellectual property | San Diego |
| Robert Yeh | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | intellectual property | Not stated |
14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 750m (US$750 million)
- What the figure measures
- Issue size
- Client
- Revolution Medicines, Inc.Issuer
- Counterparties
- Not stated